Screening for Gestational Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Description: Update of the 2008 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for gestational diabetes mellitus (GDM). Methods: The USPSTF reviewed the evidence on the accuracy of screening tests for GDM, the benefits and harms of screening before and after 24 weeks of gestation, and the benefits and harms of treatment in the mother and infant. Population: This recommendation applies to pregnant women who have not been previously diagnosed with type 1 or 2 diabetes mellitus. Recommendation: The USPSTF recommends screening for GDM in asymptomatic pregnant women after 24 weeks of gestation. (B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for GDM in asymptomatic pregnant women before 24 weeks of gestation. (I statement)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The United States Preventive Services Task Force (USPSTF) currently recommends screening for GDM in asymptomatic pregnant women after 24 weeks' gestation.40”
From One-step or 2-step testing for gestational diabetes: which is better? (2021) · cites this paper as [40]
In the citing paper
“The USPSTF justifies screening based on risk reduction to the individual mother and fetus: “The USPSTF found adequate evidence that treatment of screen-detected GDM with dietary modifications, glucose monitoring, and insulin (if needed) can significantly reduce the risk of preeclampsia, fetal macrosomia, and shoulder dystocia.When these outcomes are considered collectively, there is a moderate net”
From One-step or 2-step testing for gestational diabetes: which is better? (2021) · cites this paper as [40]
In the citing paper
“The most significant metabolic abnormality was a 20% prevalence of gestational diabetes, somewhat higher than the prevalence for the general population, which is estimated at 7% to 10% but ranges from 1% to 25% (276).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [276]
Citations
Cites
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Standards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
Gestational Diabetes and the Incidence of Type 2 Diabetes
Kim, C., Newton, K. M., & Knopp, R. H. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1862 · Cited by 2,276 · cited 2×
“In fact, 15% to 60% of women with GDM develop type 2 diabetes mellitus within 5 to 15 years postpartum (2).”
BackgroundA Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902430 · Cited by 2,122
Metzger, B. E., Gabbe, S. G., Persson, B., Lowe, L. P., Dyer, A. R., Oats, J. J. N., & Buchanan, T. A. (2010) · Diabetes Care · doi:10.2337/dc10-0719 · Cited by 1,888
Practice Bulletin No. 137: Gestational Diabetes Mellitus
(2013) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000433006.09219.f1 · Cited by 581
Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline
Blumer, I., Hadar, E., Hadden, D. R., Jovanovič, L., Mestman, J. H., Murad, M. H., & Yogev, Y. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2465 · Cited by 561
Hartling, L., Dryden, D. M., Guthrie, A., Muise, M., Vandermeer, B., & Donovan, L. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-2-201307160-00661 · Cited by 395
Naylor, C. D. (1996) · JAMA · doi:10.1001/jama.1996.03530390031030 · Cited by 343 · cited 1×
“The cohort study (n 258) showed no significant difference in preeclampsia (12).”
BackgroundU.S. Preventive Services Task Force* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-10-200805200-00008 · Cited by 291
Management of Diabetes Mellitus by Obstetrician–Gynecologists
Gabbe, S. G., Gregory, R. P., Power, M. L., Williams, S. B., & Schulkin, J. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000128045.50439.89 · Cited by 141 · cited 1×
“A cross-sectional study reported that universal screening is the most common practice in the United States, with 96% of obstetricians routinely screening for GDM (4).”
BackgroundDonovan, L., Hartling, L., Muise, M., Guthrie, A., Vandermeer, B., & Dryden, D. M. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-2-201307160-00657 · Cited by 125
Bevier, W., Fischer, R., & Jovanovic, L. (1999) · American Journal of Perinatology · doi:10.1055/s-2007-993871 · Cited by 99
Naylor, C. D. (1996) · JAMA · doi:10.1001/jama.275.15.1165 · Cited by 67
Research works printed but not linked: 1
- Vandorsten JP, 2013, NIH Consens State Sci Statements, 29, 1
Cited by
ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus
(2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002501 · Cited by 1,820
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis
Ye, W., Luo, C., Huang, J., Li, C., Liu, Z., & Liu, F. (2022) · BMJ · doi:10.1136/bmj-2021-067946 · Cited by 1,073
In Utero Exposure to Maternal Hyperglycemia Increases Childhood Cardiometabolic Risk in Offspring
Tam, W. H., Ma, R. C. W., Ozaki, R., Li, A. M., Chan, M. H. M., Yuen, L. Y., Lao, T. T. H., Yang, X., Ho, C. S., Tutino, G. E., et al. (2017) · Diabetes Care · doi:10.2337/dc16-2397 · Cited by 366
Practice Bulletin No. 180: gestational diabetes mellitus.
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002159 · Cited by 324
Metadata
- Authors
- Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force*
- Affiliations
- United States Preventive Services Task Force (US)
- Corresponding author
- Moyer, Virginia A.
- ORCID
- Moyer, Virginia A.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2014-03-18
- Volume
- 160
- Issue
- 6
- Pages
- 414-420
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W4293879493
- Semantic Scholar
- 3e0fce85de7d9d776dff46888e773b5ec0f8e8c4
- Cited by
- 223
- References
- 14
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 8 · 2023: 23 · 2022: 32 · 2021: 29 · 2020: 21 · 2019: 16 · 2018: 28 · 2017: 20 · 2016: 14 · 2015: 11 · 2014: 4
- FWCI
- 17.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
- Locations
- Annals of Internal Medicine (publishedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Maternal and Neonatal Healthcare
- Keywords
- gestational diabetes mellitus, screening, pregnant women, screening accuracy, benefits and harms, prenatal care, maternal treatment, infant outcomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.